Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

Abstract

BACKGROUND To reduce the risk of thromboembolic complications, clinical guidelines recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although warfarin has long been the primary treatment alternative, now newer alternatives such as apixaban have proven effective in prevention of the thromboembolic complications of non… (More)
DOI: 10.1186/s40064-016-3024-5

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Hallinen2016CosteffectivenessOA, title={Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients}, author={Taru A. Hallinen and Erkki J. O. Soini and Miika Linna and Samuli Ilmari Saarni}, booktitle={SpringerPlus}, year={2016} }